Ainovo Biotech Inc.

We are a next-generation biotechnology company creating an AI-powered platform for custom protein design. Our platform develops Novobinders: proprietary protein binders with diagnostic and therapeutic applications. AINovo Biotech works with select biopharmaceutical and biotechnology companies to accelerate target selection, to jointly develop novel medicines and optimize therapeutic profiles, and to inform and desrisk clinical strategy. These goals are carried out through our proprietary AINovo Biotech platform including our data engine, CURIUS, which synthesizes diverse and siloed massive datasets, to enable modern machine learning methods to solve major challenges in the development of novel and effective biologics.